Nerve-sparing retroperitoneal lymph node dissection for metastatic testicular cancer

Yoichi Arai, Satoshi Ishitoya, Kazutoshi Okubo, Yoshitaka Aoki, Takashi Okada, Hiroshi Maeda, Yuji Suzuki

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)


Background: Nerve-sparing techniques are used during retroperitoneal lymph node dissection (RPLND) in patients with early stage testicular cancer to preserve postoperative ejaculatory function. Indications for the procedures have been extended to patients with a postchemotherapy retroperitoneal residual mass without compromising the efficacy of surgery. We report 6 cases diagnosed with metastatic testicular cancer who underwent nerve-sparing RPLND. Methods: Between January 1994 and March 1996, 6 patients with metastatic testicular cancer underwent nerve-sparing RPLND. Five of these patients received primary chemotherapy and had a retroperitoneal residual mass. Four patients underwent complete bilateral RPLND and 2 underwent unilateral template surgery. Results: After a mean follow-up of 18.7 months (range, 8 to 34), there have been no local recurrences and 5 (83%) patients report antegrade ejaculation. Conclusion: Nerve-sparing RPLND is applicable for selected patients with metastatic testicular cancer without increasing the risk of local recurrence. Ejaculatory function is preserved in the majority of patients, contributing to the improvement of the quality of life in men who require such surgery.

Original languageEnglish
Pages (from-to)487-492
Number of pages6
JournalInternational Journal of Urology
Issue number5
Publication statusPublished - 1997
Externally publishedYes


  • Ejaculation
  • Lymph node excision
  • Nerves
  • Testicular cancer

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'Nerve-sparing retroperitoneal lymph node dissection for metastatic testicular cancer'. Together they form a unique fingerprint.

Cite this